Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Cancer Research UK to test Asterias’ lung cancer vaccine

The vaccine could treat NSCLC patients who are at risk of relapse

- PMLiVE

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

- PMLiVE

Exelixis appoints Andrew Peters to newly created position

He joins the biotech as its vice president, strategy

- PMLiVE

AbbVie, Roche get FDA OK for broader use of Venclexta

The drug is tipped to become a $2.5bn product by 2024

Patient outcomes in practice: delivering value that transforms lives

In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. In response to the increasing...

Lucid Group Communications Limited

Reaching the new influencers

With payers looking increasingly to real-world data, and to differentiation beyond this data through outcomes commitment and the provision of beyond the pill services, there’s never been a better time...

EU flag

UK pharma cheers EU science announcement

UK won't be excluded from Horizon research collaboration

Introducing eConnext™: The Next Generation of Online Conference Engagement

TORONTO, CANADA, June 8, 2018— Six Degrees Medical (SDM) announces the launch of eConnext™. eConnext™ combines SDM’s medical writing and pharmaceutical industry content development experience with state-of-the-art virtual meeting platforms...

Six Degrees Medical Consulting

- PMLiVE

Roche’s MabThera ends drug drought for serious skin disease

As biosimilars seize market share, Roche finds ways to extend blockbuster's revenues

- PMLiVE

If you’re going global, go local and go early

A brief arrives in your inbox. You have been asked to develop an integrated communications plan for a global healthcare company. A plan that builds disease awareness, establishes unmet needs,...

- PMLiVE

Daily Brief: Keytruda and microbiome synergy, Pfizer’s files PARP contender and more

Your daily injection of pharma news

- PMLiVE

Merck’s Brexit contingency plan? Stockpile medicines

As UK's Brexit plans remain in disarray, big pharma is making contingency plans

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links